Market Data 
Markets
Replies to post #193473 on Anavex Life Sciences Corp (AVXL)
The Government has pledged $30 million in funding to help researchers at the Australian Parkinson’s Mission search for effective treatments and the elusive cure for Parkinson’s disease.
The Australian Parkinson's Mission is a collaboration of Parkinson's Australia, the Garvan Institute of Medical Research, Garvan Research Foundation, The Cure Parkinson’s Trust (UK), Shake It Up Australia Foundation and the Michael J Fox Foundation.
"The clinical trial will seek to measure the neuroprotective effects of Anavex 2-73 and its ability to re-establish the normal function of cells," she said.
Both trial sites are involved in ongoing trials for the same drug as a treatment for Alzheimer's disease, which have shown promising results.
Parkinson's disease patients aged 50 and over who have been diagnosed with dementia will be recruited for the trial. Participants will be randomly assigned to receive Anavex 2-73 or a placebo for 14 weeks.
Researchers will evaluate the impact of the treatment on cognition as well as motor function and sleep quality.
The trial, which is also being conducted at other international sites, has received the support of the Michael J Fox Foundation for Parkinson's Research and Leon Research.
